Adelphi Trust Co Takes $1.18 Million Position in McKesson Corporation $MCK

Key Points

• Adelphi Trust Co purchased a new stake of 1,435 McKesson shares valued at approximately $1.18 million, representing about 1.0% of its holdings and making McKesson its 26th largest position.
• McKesson beat quarterly estimates with $9.34 EPS (vs. $9.19 expected) and $106.16 billion revenue (up 11.4% year-over-year), and set FY2026 guidance of 38.80–39.20 EPS while analysts' average target is about $970.93.
• Insiders sold a total of 3,592 shares (~$3.52 million) over the last three months; insiders now own just 0.08% of the stock while institutional investors hold about 85.07%.

Adelphi Trust Co bought a new stake in McKesson Corporation (NYSE:MCK - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,435 shares of the company's stock, valued at approximately $1,177,000. McKesson comprises about 1.0% of Adelphi Trust Co's holdings, making the stock its 26th biggest position.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Obsidian Personal Planning Solutions LLC boosted its stake in McKesson by 2.9% in the 3rd quarter. Obsidian Personal Planning Solutions LLC now owns 426 shares of the company's stock valued at $346,000 after buying an additional 12 shares in the last quarter. IAM Advisory LLC raised its position in McKesson by 0.3% in the 3rd quarter. IAM Advisory LLC now owns 3,908 shares of the company's stock valued at $3,019,000 after purchasing an additional 13 shares during the last quarter. PDS Planning Inc raised its position in shares of McKesson by 1.1% during the third quarter. PDS Planning Inc now owns 1,209 shares of the company's stock worth $934,000 after acquiring an additional 13 shares during the last quarter. Berkshire Asset Management LLC PA raised its position in shares of McKesson by 4.6% during the third quarter. Berkshire Asset Management LLC PA now owns 294 shares of the company's stock worth $227,000 after acquiring an additional 13 shares during the last quarter. Finally, Norden Group LLC increased its holdings in McKesson by 4.3% in the fourth quarter. Norden Group LLC now owns 317 shares of the company's stock valued at $260,000 after purchasing an additional 13 shares during the last quarter. Institutional investors and hedge funds own 85.07% of the company's stock.

Insider Buying and Selling

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm's stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Leann B. Smith sold 190 shares of McKesson stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total transaction of $179,550.00. Following the transaction, the executive vice president owned 2,989 shares of the company's stock, valued at $2,824,605. The trade was a 5.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 3,592 shares of company stock valued at $3,518,555 over the last three months. 0.08% of the stock is owned by corporate insiders.

McKesson Stock Performance

Shares of MCK opened at $862.09 on Thursday. The firm has a market capitalization of $105.60 billion, a P/E ratio of 24.79, a P/E/G ratio of 1.24 and a beta of 0.42. The stock has a 50 day moving average price of $917.65 and a two-hundred day moving average price of $853.54. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating the consensus estimate of $9.19 by $0.15. The business had revenue of $106.16 billion during the quarter, compared to analyst estimates of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.McKesson's revenue was up 11.4% compared to the same quarter last year. During the same period in the prior year, the company earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd were paid a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend was Monday, March 2nd. McKesson's dividend payout ratio (DPR) is 9.43%.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the company. Wall Street Zen downgraded McKesson from a "buy" rating to a "hold" rating in a report on Saturday, April 11th. Leerink Partners reaffirmed an "outperform" rating and issued a $1,085.00 price objective on shares of McKesson in a research report on Thursday, March 5th. Robert W. Baird set a $968.00 price target on McKesson in a report on Wednesday, January 14th. Barclays raised their price objective on McKesson from $960.00 to $1,050.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 18th. Finally, Mizuho lifted their price target on McKesson from $880.00 to $885.00 and gave the company a "neutral" rating in a research note on Thursday, February 5th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, McKesson has an average rating of "Moderate Buy" and an average target price of $970.93.

About McKesson

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.